A multicentre, non-interventional study to evaluate long-term safety in patients with achondroplasia treated with Voxzogo® (vosoritide) (BMN 111-603) First published 20/10/2022 Last updated 23/04/2024 EU PAS number:EUPAS47514 Study Ongoing